See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Natural Disasters
Baseball
Donald Trump
Trade War
Social Media
Artificial Intelligence
Senate
Trade
Stock Markets
Taxes
Published • loading... • Updated

Abeona planning potential US launch of pz-cel to treat RDEB

Summary by Epidermolysis Bullosa News
Abeona Therapeutics is preparing for the potential launch of pz-cel (prademagene zamikeracel) to treat recessive dystrophic epidermolysis bullosa (RDEB), after the U.S. Food and Drug Administration (FDA) initiated discussions on the medication label and post-marketing requirements, according to a company press release. Last fall, the FDA indicated April 29 as the deadline by which it will decide whether or not to approve pz-cel for RDEB. That da…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Epidermolysis Bullosa NewsEpidermolysis Bullosa News

Abeona planning potential US launch of pz-cel to treat RDEB

Abeona Therapeutics is preparing for the potential launch of pz-cel (prademagene zamikeracel) to treat recessive dystrophic epidermolysis bullosa (RDEB), after the U.S. Food and Drug Administration (FDA) initiated discussions on the medication label and post-marketing requirements, according to a company press release. Last fall, the FDA indicated April 29 as the deadline by which it will decide whether or not to approve pz-cel for RDEB. That da…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Epidermolysis Bullosa News broke the news in on Friday, March 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Mississippi

Mississippi

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal